International Journal of Obstetric Anesthesia
Volume 18, Issue 3 , Pages 242-248, July 2009

The preparation and storage of anaesthetic drugs for obstetric emergencies: a survey of UK practice

  • J.P. Stone
  • ,
  • L.B. Fenner
  • ,
  • T.R. Christmas

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr. T. R. Christmas, Department of Anaesthetics, Great Western Hospital, Marlborough Road, Swindon, SN3 6BB. Tel.: +01793 605229; fax: +01793 605232.

Department of Anaesthesia, Great Western Hospital, Swindon, UK

Accepted 31 January 2009. published online 25 May 2009.

Abstract 

Background

Traditionally anaesthetic drugs for obstetrics are prepared as a contingency and stored until they are required for emergency use or have expired. Expiry is based on presumed reduction in sterility and efficacy although evidence for this is inconsistent. Preparation in advance introduces the risk of error and potential for tampering by a third party. Discarding and re-preparing drugs daily represents significant wastage with associated cost implications. We predicted that practice of drug preparation would differ widely across the UK, so conducted a national survey.

Method

A postal questionnaire was sent to lead consultant obstetric anaesthetists at each of the 223 consultant-led UK obstetric units enquiring about the preparation of anaesthetic drugs for obstetric emergencies.

Results

The response rate was 75%; 87% of units routinely draw up emergency drugs, most commonly thiopental and succinylcholine. Only 10% routinely use commercially-prepared succinylcholine syringes, although a further 8% would use them if available. Thiopental is prepared by anaesthetists in 78% of units, operating department practitioners in 8% and pharmacy in <7% of cases. Drugs are changed every 24h in 80% of units and weekly in 6%. With one exception, all units changing drugs weekly use pharmacy-prepared thiopental.

Conclusion

The majority of UK obstetric units routinely draw up emergency drugs every 24h. With conflicting evidence regarding sterility and efficacy this represents tremendous wastage and potential for drug error and tampering. We propose that nationwide introduction of commercially- and pharmacy-prepared drugs with long shelf lives would improve safety and cost effectiveness.

Keywords: Anesthesia, obstetrical, Drug, costs, Drug, preparation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented, in part, as a poster at Obstetric Anaesthesia 2008, Belfast, Northern Ireland, UK, and as an oral presentation at the Wessex Obstetric Anaesthetists Meeting June 2008, Bournemouth, UK.

PII: S0959-289X(09)00042-9

doi:10.1016/j.ijoa.2009.01.013

International Journal of Obstetric Anesthesia
Volume 18, Issue 3 , Pages 242-248, July 2009